Dermasim® is the preparation of Clotrimazole which is a broad-spectrum antifungal. It also exhibits activity against Trichomonas, Staphylococci, Streptococci and Bacteroides.
No Data
Dermasim® is indicated mould and for all other fungi dermatomycoses and skin due diseases to showing dermatophytes superinfections (e.g., with Trichophyton these fungi. species), yeasts (e.g., Candida species), mould and other fungi and skin diseases showing superinfections with these fungi.
The above mentioned dermatomycoses include interdigital mycoses (e.g., athlete's foot), paronychias (associated with nail mycoses), mycoses in skin and skin folds, candida vulvitis, candida balanitis, pityriasis versicolor, ringworn and erythrasma.
Route of administration: Dermasim® 1 % Cream should be applied topically.
Wash skin with soap and water and dry thoroughly. Apply a thin layer of the cream 2-3 times daily and gently message
over Best results affected in area athlete's as directed foot and by the ringworm physician. are For usually athlete's obtained foot, with pay 4 special weeks use attention of this to the product spaces and in between jock itch the with toes. 2
weeks disappearance use. The of all cream signs of should be inrection. applied If two satisfactory or three results times have daily not for occurred one month within or these for at times, least consult two a weeks physician. after the For best results, follow the directions and continue treatment for length of time indicated.
Candida Dermatomycoses: vulvitis and 3-4 candida weeks. balanitis: 1-2 weeks.
Erythrasma and pityriasis versicolor: (approx.) 3 weeks.
In fungal disappearance infection of all of signs the of feet, disease. to prevent relapses, treatment should be continued for about 2 weeks beyond the
Pregnancy: Clotrimazole can be used during pregnancy but only under the supervision of a physician.
Lactation: As many drugs are excreted in human milk, a decision must be made whether to discontinue breastfeeding or to discontinue clotrimazole therapy.
For external use only. Not intended for ophthalmic use. Discontinue the product if skin rash or new irritation occurs.
Local reactions including skin irritation and burning may occur. Contact allergic dermatitis has also been reported.
Possible hypersensitivity to clotrimazole or any other ingredients or the product.
When used together, this cream may cause damage to latex contraceptives. Consequently the effectiveness of such contraceptives may be reduced. Patients should be advised to use alternative precautions for at least five days after using this cream.
No risk of acute intoxication is seen as it is unlikely to occur following a single dermal application of an overdose or inadvertent oral ingestion. There is no specific antidote.
No Data
Store in a cool (below 25°C) and dry place protected from light. Keep away from the reach of children.
Dermasim® 1% Cream: Each gram contains Clotrimazole BP 10 mg.
Denmasim® 1% Cream: Tube or 15 g.